|
|
|
|
Vol. 59, Issue 6, 1402-1409, June 2001
Institute of Pharmacology and Toxicology, Department of Toxicology,
University of Göttingen, Germany
Xenobiotic-metabolizing cytochrome P-450 (P-450) enzymes not only play
a pivotal role in elimination of foreign compounds but also contribute
to generation of toxic intermediates, including reactive oxygen
species, that may elicit cellular damage if produced excessively.
Expression of several xenobiotic-metabolizing P-450 enzymes is induced
by phenobarbital (PB). Pronounced induction is observed for the rat
CYP2B1 isoform. A primary rat hepatocyte culture system was used to
investigate whether reactive oxygen species might modulate PB-dependent
CYP2B1 induction. In cells cultivated for 3 days with 1.5 mM PB,
substantial CYP2B1 mRNA induction was observed (100%). Addition of
H2O2 or of the catalase inhibitor
3-amino-1,2,4-triazole (AT) to the medium repressed induction to
approximately 30% (at 1 mM H2O2 and 2 mM AT,
respectively). Accordingly, treatment of hepatocytes with PB and the
glutathione precursor N-acetylcysteine (NAC) led to
enhanced PB-dependent induction (to over 1000% at 10 mM NAC). In
primary hepatocyte cultures transfected with a
CYP2B1 promoter-luciferase construct containing
approximately 2.7 kilobase pairs of the native CYP2B1 promoter sequence, PB-dependent reporter gene activation was repressed by AT and stimulated by N-acetylcysteine. Furthermore, a
263-base pair CYP2B1 promoter fragment encompassing the
phenobarbital-responsive enhancer module conferred suppression of
PB-dependent luciferase expression by AT and activation by NAC in a
heterologous SV40-promoter construct. In summary, these
data demonstrate a regulatory mechanism that is dependent on the
cellular redox status, which modulates CYP2B1 mRNA induction by PB on
the transcriptional level, thus representing a feedback mechanism
preventing further P-450-dependent production of reactive oxygen
intermediates under oxidative stress.
This article has been cited by other articles:
![]() |
J. Zukunft, T. Lang, T. Richter, K. I. Hirsch-Ernst, A. K. Nussler, K. Klein, M. Schwab, M. Eichelbaum, and U. M. Zanger A Natural CYP2B6 TATA Box Polymorphism (-82T-> C) Leading to Enhanced Transcription and Relocation of the Transcriptional Start Site Mol. Pharmacol., May 1, 2005; 67(5): 1772 - 1782. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bauer, N. Wolfram, G. F. Kahl, and K. I. Hirsch-Ernst Transcriptional Regulation of CYP2B1 Induction in Primary Rat Hepatocyte Cultures: Repression by Epidermal Growth Factor Is Mediated via a Distal Enhancer Region Mol. Pharmacol., January 1, 2004; 65(1): 172 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Handschin and U. A. Meyer Induction of Drug Metabolism: The Role of Nuclear Receptors Pharmacol. Rev., December 1, 2003; 55(4): 649 - 673. [Abstract] [Full Text] [PDF] |
||||